Immune response agaisnt tumors and transplants

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/10

encourage image

There's no tags or description

Looks like no tags are added yet.

11 Terms

1
New cards

What is the clinical challenge with tumors

How do we enhance immunity

2
New cards

What is the clinical challenge of transplants

How to suppress immune response to grafts

3
New cards

What is the primary cell type common between tumor and transplants responses.

CTLs which attempt to destroy both because they are identified as foreign

4
New cards

Describe tumor antigens

Malignant tumors express various types of molecules that my be recognized as foreign

But it is a sloppy response because immune system can’t decide how “strong” of a response to induce

5
New cards

Who fights against tumor cell killing

NK cells and Activated macrophages via ADCC

Activated cytotoxic cells via CTLs/APCs

6
New cards

Immune mechanisms of tumor rejection or destruction

  1. Principal mechanics involves killing of tumors by CTLs specific to tumor antigens. (cross presentation)

  2. NK cells: ADCC and lysis

  3. Macrophages: produce inflammatory cytokines and ADCC


7
New cards
<p>Describe evasion of immune responses to tumors</p>

Describe evasion of immune responses to tumors

Tumors stop expressing antigens

Tumors stop expressing MHCs

Immune response suppression: cytokines, CTLA-4, Tregs

8
New cards

Transfer of autologous T cells for enhancing anti-tumor immune responses

T cells removed from patients blood and expanded in vitro and then put back in

Monoclonal antibodies specific for tumor antigen put back into patient

Results in CMI or Antibody mediated killing of tumor

9
New cards

Describe DC vaccines for enhancing anti-tumor immune responses

DC with tumors antigens are administer to patient

Tumor antigens presented to T cells removed

T cell activation

10
New cards

Describe Tumor immunotherapy immune checkpoint blockade

If native T cells bind with PD-1 it results normal inhibition of CMI but if Anit - PD-1 is administered it initiates CMI respones on tumors

Similar to what takes place with DCs and CTLA-4 binding in lymphoid tissues.

11
New cards